The Asia Pacific advanced wound care market size is anticipated to reach USD 2.48 billion by 2030 and is projected to grow at a CAGR of 5.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising incidence of chronic wounds is the major factor contributing to the market growth. For instance, in January 2023, MiMedx Group, Inc., a prominent player in placental biologics, secured an exclusive distribution partnership with Gunze Medical Limited, a subsidiary of Gunze Limited, to market EPIFIX exclusively in Japan.
Improvements in healthcare infrastructure and surgical accessibility drive demand for advanced wound care solutions, spurred by increasing surgical procedures and the prevalence of chronic diseases and age-related conditions. According to the United Nations ESCAP (Economic and Social Commission for Asia and the Pacific, by 2023, Asia and the Pacific were expected to have approximately 697 million individuals aged 60 years or older, constituting approximately 60% of the global older population, with one in every 7 individuals in the region falling into this age group. Projections indicated that by 2050, one in every 4 individuals in the region will be aged 60 years or older.
Moreover, the rising prevalence of chronic ailments such as diabetes, cancer, and autoimmune disorders is expected to elevate the occurrence of chronic wounds in the Asia Pacific region. According to the World Health Organization (WHO), within the WHO South-East Asia Region, diabetes affects over 96 million individuals, leading to significant economic burdens on patients, their families, healthcare systems, and national economies due to associated complications like blindness, kidney failure, heart attacks, strokes, and lower limb amputations.
Request a free sample copy or view report summary: Asia Pacific Advanced Wound Care Market Report
Based on product, the moist segment led the market with the largest revenue share of 70.9% in 2023, owing to increasing geriatric population in many Asian countries, coupled with rising incidences of chronic diseases such as diabetes, which has led to a higher prevalence of chronic injuries that require advanced wound care solutions. Also, the active segment is expected to grow at the fastest CAGR over the forecast period
Based on application, the chronic wounds segment held the market with the largest revenue share of 59.4% in 2023, owing to the technological advancements, encompassing a range of solutions, such as advanced injuries dressings, negative pressure wound therapy systems, bioactive wound care products, and topical oxygen therapy devices, among others. On other hand, the acute wounds segment is expected to grow at the fastest CAGR over the forecast period
Based on end-use, hospitals segment led the market with the largest revenue share of 45.4% in 2023, as chronic diseases and aging increase, hospitals face more patients needing advanced wound care, which boosts the demand for related products and treatments. The home healthcare segment is expected to grow at the fastest CAGR over the forecast period
In September 2023, Microsoft and healthcare technology company Paige collaborated to develop the most extensive image-based artificial intelligence (AI) models for digital pathology and oncology globally. This initiative seeks to revolutionize cancer diagnosis and enhance patient care. Leveraging advancements in the field, the partnership aspires to create a transformative impact on how cancer is diagnosed and treated, ultimately contributing to advancements in healthcare technology
Grand View Research has segmented the Asia Pacific advanced wound care market report based on product, application, end-use, and country:
Asia Pacific Advanced Wound Care Product Outlook (Revenue, USD Million, 2018 - 2030)
Moist
Foam Dressings
Hydrocolloid Dressings
Film Dressings
Alginate Dressings
Hydrogel Dressings
Collagen Dressings
Other Advanced Dressings
Antimicrobial
Silver
Non-silver
Active
Biomaterials
Skin-substitute
Growth Factors
Asia Pacific Advanced Wound Care Application Outlook (Revenue, USD Million, 2018 - 2030)
Chronic Wounds
Diabetic Foot Ulcers
Pressure Ulcers
Venous Leg Ulcers
Other Chronic Wounds
Acute Wounds
Surgical & Traumatic Wounds
Burns
Asia Pacific Advanced Wound Care End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Specialty Clinics
Home Healthcare
Others
Asia Pacific Advanced Wound Care Country Outlook (Revenue, USD Million, 2018 - 2030)
Asia Pacific
Japan
China
India
South Korea
Australia
Thailand
List of Key Players in the Asia Pacific Advanced Wound Care Market
Mölnlycke Health Care AB
3M
Smith & Nephew
Baxter
Cardinal Health
Medline Industries, Inc.
ConvaTec Inc.
MIMEDX Group, Inc.
L&R Group of Companies
Johnson & Johnson Services, Inc.
Integra LifeSciences Corporation
B. Braun SE
Coloplast Group
Hollister Incorporated
Zimmer Biomet
Medtronic
Elkem ASA
"The quality of research they have done for us has been excellent..."